Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
Diabetes & Metabolism Journal · 31.01.2023 · 47 (1) · 92-103
DOI: 10.4093/dmj.2021.0370 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 31.01.2023. Verfasst von Minji Sohn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Insulin Resistance, Lactiplantibacillus plantarum. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medytox, Seoul National University Bundang Hospital.
Abstract (Originalsprache)
Background
We investigated whether Lactobacillus plantarum strain LMT1-48, isolated from Korean fermented foods and newborn feces, is a suitable probiotic supplement to treat overweight subjects.
Methods
In this randomized, double-blind, placebo-controlled clinical trial, 100 volunteers with a body mass index of 25 to 30 kg/m2 were assigned randomly (1:1) to receive 2×1010 colony forming units of LMT1-48 or to a placebo treatment group. Body composition was measured by dual-energy X-ray absorptiometry, and abdominal visceral fat area (VFA) and subcutaneous fat area were measured by computed tomography scanning. Changes in body fat, VFA, anthropometric parameters, and biomarkers were compared between the two treatment groups (ClinicalTrials.gov number: NCT03759743).
Results
After 12 weeks of treatment, the body weight decreased significantly from 76.6±9.4 to 75.7±9.2 kg in the LMT1-48 group but did not change in the placebo group (P=0.022 between groups). A similar pattern was found in abdominal VFA between the two groups (P=0.041). Serum insulin levels, the corresponding homeostasis model assessment of insulin resistance, and leptin levels decreased in the LMT1-48 group but increased in the placebo group (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Medytox Inc., Seoul, Korea.
- Medytox Gwangkyo R&D Center, Suwon, Korea.
Förderung
- Medytox
- Seoul National University Bundang Hospital
Zitieren
APA
Sohn, M., Jung, H., Lee, W. S., Kim, T. H., & Lim, S. (2023). Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes & Metabolism Journal, 47(1), 92-103. https://doi.org/10.4093/dmj.2021.0370
Vancouver
Sohn M, Jung H, Lee WS, Kim TH, Lim S. Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes & Metabolism Journal. 2023;47(1):92-103. doi:10.4093/dmj.2021.0370
BibTeX
@article{Sohn2023,
author = {Sohn, Minji and Jung, Hyeyoung and Lee, Woo Shun and Kim, Tai Hoon and Lim, Soo},
title = {Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {Diabetes & Metabolism Journal},
year = {2023},
volume = {47},
number = {1},
pages = {92--103},
doi = {10.4093/dmj.2021.0370}
}
EUVIMED